Literature DB >> 8409927

Cell wall assembly in Staphylococcus aureus: proposed absence of secondary crosslinking reactions.

D Gally1, A R Archibald.   

Abstract

The distribution of muropeptides formed by muramidase digestion of peptidoglycan from Staphylococcus aureus H was determined by gel-filtration HPLC. The observed crosslinking pattern supports the conclusion that incorporation of peptidoglycan in S. aureus proceeds by a similar mechanism to that proposed earlier for Bacillus megaterium. In this mechanism single glycan-peptide strands are incorporated into the sacculus by crosslinking reactions that take place only between the monomer muropeptide units of the incoming glycopeptide and muropeptides present in the innermost region of wall at the wall-membrane interface: such crosslinking reactions take place only during incorporation and no other crosslinking reactions occur. This assembly process has now been termed restricted monomer addition. The present analysis shows that the distribution of muropeptides in S. aureus peptidoglycan is in excellent agreement with that predicted by this mechanism. We propose that cell wall assembly in S. aureus proceeds via restricted monomer addition without any requirement for the secondary crosslinking reactions that have been suggested to occur in this organism. The high degree of crosslinking in S. aureus, 80% in this study, may result mainly from the freedom for crosslinking provided by the pentaglycine bridge peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409927     DOI: 10.1099/00221287-139-8-1907

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  13 in total

1.  Tertiary structure of bacterial murein: the scaffold model.

Authors:  Boris A Dmitriev; Filip V Toukach; Klaus-Jürgen Schaper; Otto Holst; Ernst T Rietschel; Stefan Ehlers
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

2.  Native cell wall organization shown by cryo-electron microscopy confirms the existence of a periplasmic space in Staphylococcus aureus.

Authors:  Valério R F Matias; Terry J Beveridge
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

Review 3.  Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria.

Authors:  Luciano A Marraffini; Andrea C Dedent; Olaf Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

4.  The Staphylococcus aureus cidAB operon: evaluation of its role in regulation of murein hydrolase activity and penicillin tolerance.

Authors:  Kelly C Rice; Brian A Firek; Jeremy B Nelson; Soo-Jin Yang; Toni G Patton; Kenneth W Bayles
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

5.  Staphylococcus aureus mutants with increased lysostaphin resistance.

Authors:  Angelika Gründling; Dominique M Missiakas; Olaf Schneewind
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

6.  Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus.

Authors:  Magda L Atilano; Pedro M Pereira; James Yates; Patricia Reed; Helena Veiga; Mariana G Pinho; Sérgio R Filipe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-13       Impact factor: 11.205

7.  Tertiary structure of Staphylococcus aureus cell wall murein.

Authors:  Boris A Dmitriev; Filip V Toukach; O Holst; E T Rietschel; S Ehlers
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

8.  Peptidoglycan architecture of Gram-positive bacteria by solid-state NMR.

Authors:  Sung Joon Kim; James Chang; Manmilan Singh
Journal:  Biochim Biophys Acta       Date:  2014-06-08

9.  Characterization of the peptidoglycan of vancomycin-susceptible Enterococcus faecium.

Authors:  Gary J Patti; Sung Joon Kim; Jacob Schaefer
Journal:  Biochemistry       Date:  2008-07-19       Impact factor: 3.162

10.  Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus.

Authors:  Daniela Münch; Terry Roemer; Sang Ho Lee; Marianne Engeser; Hans Georg Sahl; Tanja Schneider
Journal:  PLoS Pathog       Date:  2012-01-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.